Café

© 2026 Longbridge｜Terms of Service Privacy Policy

BGLC

BGLC

1.6405.81%( +0.090 )

LongbridgeAI

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News

StockTitan

Mar 10, 2026 at 11:45 PM

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News

Login to unlock202characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

BioNexus Gene Lab

USBGLC

+5.81%

First Trust NYSE Arca Biotech Index Fd

USFBT

iShares Biotechnology ETF

USIBB